2003
DOI: 10.1016/s1062-1458(02)01007-3
|View full text |Cite
|
Sign up to set email alerts
|

Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
46
0
3

Year Published

2003
2003
2016
2016

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(51 citation statements)
references
References 0 publications
1
46
0
3
Order By: Relevance
“…Clinically, the interaction does not appear to affect the ACE inhibitor's ability to prevent adverse cardiovascular or renal outcomes. 41 ACE inhibitors may increase hypersensitivity reactions, such as flulike symptoms and skin rash, with allopurinol, although the exact mechanism is not known. 7 ACE inhibitors and ARBs may increase lithium levels, and concurrent use warrants close monitoring of lithium levels.…”
Section: Ace Inhibitors and Arbsmentioning
confidence: 99%
“…Clinically, the interaction does not appear to affect the ACE inhibitor's ability to prevent adverse cardiovascular or renal outcomes. 41 ACE inhibitors may increase hypersensitivity reactions, such as flulike symptoms and skin rash, with allopurinol, although the exact mechanism is not known. 7 ACE inhibitors and ARBs may increase lithium levels, and concurrent use warrants close monitoring of lithium levels.…”
Section: Ace Inhibitors and Arbsmentioning
confidence: 99%
“…Although some retrospective analyses have suggested that coadministration of these drugs decreases the mortality benefit associated with ACEI therapy in patients with heart failure or ischemic heart disease, other studies have suggested that a decrease in mortality does not occur. 10 Because aspirin 81 mg/d has the same efficacy as 325 mg/d, with half the bleeding risk, 11 J.D. was advised to take the lower aspirin dose with the additional theoretical possibility that any interaction with his ACEI would be decreased.…”
Section: The Aspirin-ace Inhibitor Drug-drug Interactionmentioning
confidence: 99%
“…АСК в дозах 75-325 мг в сутки является основным препаратом для вторичной профилактики кардио-васкулярных событий у больных с разными прояв-лениями ИБС -и при стабильной стенокардии, и с ОКС, и с постинфарктным кардиосклерозом, осложненным развитием ХСН. Также очень часто она используется в комбинации с ИАПФ [22]. Однако вопрос о целесообразности совместного применения ИАПФ и ацетилсалициловой кислоты вызывает много споров и до настоящего времени остается открытым [23].…”
Section: рис 2 рекомендации по выбору антигипертензивной терапии рunclassified